http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103070835-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bffe926681f73580c63f8bbeff581d9f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a6aef020b789f931f4c9f197d7c6439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_066d1ab69cdd7fa357e478b12db2c6a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87ba518aaaa1cbb54cc479926ea1a410
publicationDate 2015-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103070835-B
titleOfInvention Freeze-dried composition containing bortezomib and preparation method of freeze-dried composition
abstract The invention belongs to the technical field of medicine, in particular to the field of chemical pharmacy, and particularly relates to a freeze-dried composition containing bortezomib and a preparation method of the freeze-dried composition. The freeze-dried composition and the preparation method aim at overcoming main medicine dissolution difficulty and oxygen environment sensitivity in an environment. A mixed solvent comprising mannitol and tert butyl alcohol is used, so that a dissolution rate of bortezomib is increased significantly, and the dissolution rate of bortezomib can be increased further through an addition sequence of materials. A nitrogen filled environment is used, so that liquid preparation time is shortened greatly, the contact of main medicine components with an aerobic environment is avoided effectively, and contents of relevant substances and total impurities in a final finished product are reduced.
priorityDate 2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID557566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431904250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483890
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415783739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID490628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478079
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139620
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID426049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6386
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86621318
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID101107261
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID101842838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID109660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448549996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25627
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID447843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316

Total number of triples: 48.